Cancer treatment centers face critical drug shortages.
TL;DR Summary
Shortages of chemotherapy drugs cisplatin and carboplatin have disrupted cancer treatments across the US, including in Pittsburgh. The FDA temporarily shut down platinum drug shipments from a factory in India in December 2022, the primary supplier. The FDA is collaborating with Qilu Pharmaceutical Co. in China and Apotex in Canada to increase the availability of the drugs. Managing the shortage, hospitals are seeking alternative sources for medicines that are in short supply and adjusting chemotherapy regimens for impacted patients.
- Chemo drug shortages hit cancer treatment centers across Pittsburgh region TribLIVE
- How the Shortage of a $15 Cancer Drug Is Upending Treatment The New York Times
- 'It's Worrisome': Shortage Of Common Drug Impacting Oklahomans Battling Cancer, Doctor Says News On 6
- Chemotherapy drug shortage impacts cancer patients, Ohio hospitals The Columbus Dispatch
- The Cancer-Drug Shortage Is a Disaster The Atlantic
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
4 min
vs 5 min read
Condensed
92%
933 → 79 words
Want the full story? Read the original article
Read on TribLIVE